Content for Policies
If you're having trouble finding what you're looking for, consider using fewer words in your search criteria. Results are limited to content that matches all terms in the search field.
We found - potentially matching ""
Advanced Search Options
This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (o), establishes Defense Health Agency’s (DHA) procedures to implement Reference (d), for erythrocyte G6PD deficiency and SCT screening at the appropriate points: during entry to the Military Services (at appointment, enlistment, or induction (Reference (j)), at pre-deployment, and at other points as indicated for validation of results (per References (k), (m), and (n)).
This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) through (c), and in accordance with the guidance of References (d) and (e): • Establishes the Defense Health Agency’s (DHA) procedures to complete and close open encounters within the legacy systems in preparation for the implementation of Military Health System (MHS) GENESIS. • Identifies and delineates responsibilities associated with completing and closing open encounters within the legacy systems in preparation for the implementation of MHS GENESIS. • Should be used by DoD military treatment facilities (MTFs) to update procedures and workflows that pertain to the DoD Health Record Management, Patient Administration, and other MTF functions impacted by these decisions. • Is effective immediately; it must be incorporated into a DHA-Procedural Instruction. This DHA-IPM will expire effective 12 months from the date of issue.
This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) through (c), and in accordance with the guidance of References (d) through (g): • Assigns responsibilities and provides instructions for implementing Reference (d), which requires an MHA for Service members prior to separation in accordance with References (e) through (g). • Is effective immediately; it will be incorporated into DHA-Procedural Instruction xxxx.xx, “Separation History and Physical Examination.” This DHA-IPM will expire effective 12 months from the date of issue.
This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (p): • Establishes the Defense Health Agency’s (DHA) procedures for the physical custody and control of DoD Health Records at all DoD Military Treatment Facilities (MTFs) and the management, monitoring, review, and evaluation of DoD Health Record availability at MTFs. • This DHA-IPM is effective immediately and will expire effective 12 months from the date of issue. It must be incorporated into the forthcoming DHA-Procedural Instruction, “Health Records Management”.
This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (f): • Establishes the Military Health System’s (MHS) guidance for the provision of HIV PrEP for persons at high risk of HIV acquisition (ACQ). • Describes the elements and resources required to implement an HIV PrEP program. • Establishes the indications for HIV PrEP, laboratory (lab) testing and monitoring, and prescribing of HIV PrEP. • Provides a link to an HIV PrEP toolkit for providers. • This DHA-IPM is effective immediately; it will be converted to a DHA-Procedural Instruction. This DHA-IPM will expire effective 12 months from the date of issue.
This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) through (c), and in accordance with the guidance of References (d) through (v), establishes Defense Health Agency’s (DHA) procedures to: • Establish the overarching guidance to implement policies and procedures for managing DHA Deputy Assistant Director, Information Operations (DAD IO)/J-6 Defense Health Program (DHP) IT resources. The DHA Investment Management Framework is used as an enabler for MHS leadership to make informed transparent financial decisions associated with the DHA DAD IO/J-6 systems, services, and capabilities and will continue to be used in the foreseeable future. • Provide full and total awareness of all IT across the enterprise ensuring all MHS healthcare-related IT investments are accounted for and integrated both operationally and financially. This includes all IT systems, applications, and devices and all their funding identified to manage a coherent and integrated healthcare capability across the enterprise. • Provide and supersede guidance and instructions previously provided through the Services. As Military Medical Treatment Facilities (MTFs) transition to DHA management and responsibility, procedures in this DHA-IPM will supersede IT systems guidance and instructions previously provided through the Services; including IT systems in all MTFs, clinics, and enterprise services provided to Other Lines-of-Business (OLB), such as training and research, etc. In addition, it supports a coherent and comprehensive catalog of IT capability investments encompassing all IT used to support the MHS mission. • Require that all funding sources, type and Budget Activity Group (BAG), purchasing or supporting any IT must be identified for inclusion in the DHA portfolio of IT capability investments. • Provide superseding guidance and instruction, through this DHA-IPM until a DHA-Procedural Instruction is issued previously provided by the Services in References (w) through (ad), for the MTFs as they are transitioned to DHA management and responsibility. • This DHA-IPM is effective immediately and it will be converted into a DHA-Procedural Instruction. This DHA-IPM will expire effective 12 months from the date of issue.
DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101
The appearance of hyperlinks does not constitute endorsement by the Defense Health Agency of non-U.S. Government sites or the information, products, or services contained therein. Although the Defense Health Agency may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such links are provided consistent with the stated purpose of this website.